Insider · CIK 0001640447

Neylan John F.

Reports to the SEC for 2 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001640447

Forms 4 and 5

Insider transactions

43 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-03-02	ELTXElicio Therapeutics, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+175K sh	—	—	175,000
2022-03-02	ELTXElicio Therapeutics, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+100K sh	—	—	275,000
2021-12-20	ELTXElicio Therapeutics, Inc.S Sale	See Remarks	SSale	−358 sh	$2.62	−$937.996	35,136
2021-11-18	ELTXElicio Therapeutics, Inc.S Sale	See Remarks	SSale	−374 sh	$4.13	−$1,544.62	35,494
2021-10-18	ELTXElicio Therapeutics, Inc.S Sale	See Remarks	SSale	−373 sh	$8.62	−$3,215.26	35,868
2021-09-20	ELTXElicio Therapeutics, Inc.S Sale	See Remarks	SSale	−376 sh	$10.07	−$3,786.32	36,241
2021-08-18	ELTXElicio Therapeutics, Inc.S Sale	See Remarks	SSale	−381 sh	$9.03	−$3,440.43	36,617
2021-07-21	ELTXElicio Therapeutics, Inc.S Sale	See Remarks	SSale	−365 sh	$10.98	−$4,007.7	36,998
2021-06-18	ELTXElicio Therapeutics, Inc.S Sale	See Remarks	SSale	−366 sh	$13.20	−$4,831.2	37,363
2021-05-18	ELTXElicio Therapeutics, Inc.S Sale	See Remarks	SSale	−363 sh	$13.91	−$5,049.33	37,729
2021-04-19	ELTXElicio Therapeutics, Inc.S Sale	See Remarks	SSale	−381 sh	$13.55	−$5,162.55	38,092
2021-03-17	ELTXElicio Therapeutics, Inc.S Sale	See Remarks	SSale	−442 sh	$19.13	−$8,455.46	38,453
2021-02-04	ELTXElicio Therapeutics, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+70K sh	—	—	70,012
2018-12-12	KERYX BIOPHARMACEUTICALS INCD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−148K sh	—	—	0
2018-12-12	KERYX BIOPHARMACEUTICALS INCStock OptionD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−773K sh	—	—	0
2018-11-15	KERYX BIOPHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−1,156 sh	$2.77	−$3,202.12	148,279
2018-10-29	KERYX BIOPHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−1,253 sh	$3.07	−$3,846.71	149,435
2018-08-15	KERYX BIOPHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−1,186 sh	$3.04	−$3,605.44	150,688
2018-07-30	KERYX BIOPHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−1,282 sh	$3.86	−$4,948.52	151,874
2018-05-15	KERYX BIOPHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−1,158 sh	$5.69	−$6,589.02	153,156
2018-04-30	KERYX BIOPHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−1,311 sh	$4.67	−$6,122.37	154,314
2018-04-23	KERYX BIOPHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−1,111 sh	$4.59	−$5,099.49	155,625
2018-03-20	KERYX BIOPHARMACEUTICALS INCA Award	Chief Medical Officer	AAward	+41.3K sh	—	—	156,736
2018-03-20	KERYX BIOPHARMACEUTICALS INCStock Options (right to buy)A Award	Chief Medical Officer	AAward	+82.5K sh	—	—	82,500
2018-02-15	KERYX BIOPHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−5,652 sh	$4.81	−$27.2K	115,486
2018-01-29	KERYX BIOPHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−1,541 sh	$4.81	−$7,412.21	121,138
2018-01-23	KERYX BIOPHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−1,322 sh	$4.92	−$6,504.24	122,679
2017-10-30	KERYX BIOPHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−1,405 sh	$6.03	−$8,472.15	124,001
2017-10-23	KERYX BIOPHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−1,179 sh	$6.53	−$7,698.87	125,406
2017-07-31	KERYX BIOPHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−1,445 sh	$7.14	−$10.3K	126,585
2017-07-24	KERYX BIOPHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−1,214 sh	$7.27	−$8,825.78	128,030
2017-05-01	KERYX BIOPHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−1,441 sh	$5.97	−$8,602.77	129,244
2017-04-24	KERYX BIOPHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−1,209 sh	$5.73	−$6,927.57	130,685
2017-02-14	KERYX BIOPHARMACEUTICALS INCA Award	Chief Medical Officer	AAward	+48.8K sh	—	—	131,894
2017-02-14	KERYX BIOPHARMACEUTICALS INCEmployee Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+97.5K sh	—	—	97,500
2017-01-30	KERYX BIOPHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−6,984 sh	$4.65	−$32.5K	83,144
2017-01-23	KERYX BIOPHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−1,428 sh	$5.39	−$7,696.92	90,128
2016-10-24	KERYX BIOPHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−1,211 sh	$4.72	−$5,715.92	91,556
2016-07-25	KERYX BIOPHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−1,217 sh	$7.43	−$9,042.31	92,767
2016-04-25	KERYX BIOPHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−4,766 sh	$5.21	−$24.8K	93,984
2016-01-28	KERYX BIOPHARMACEUTICALS INCA Award	Chief Medical Officer	AAward	+53.8K sh	—	—	98,750
2016-01-28	KERYX BIOPHARMACEUTICALS INCEmployee Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+108K sh	—	—	107,500
2015-08-12	KERYX BIOPHARMACEUTICALS INCP Purchase	Chief Medical Officer	PPurchase	+10K sh	$6.20	+$62K	55,000

Recent filings

Accepted (ET)
Mar 44
Neylan John F.0001601485-22-000013
SEC(opens sec.gov)
Dec 214
Neylan John F.0001601485-21-000091
SEC(opens sec.gov)
Nov 224
Neylan John F.0001601485-21-000077
SEC(opens sec.gov)
Oct 204
Neylan John F.0001601485-21-000062
SEC(opens sec.gov)
Sep 214
Neylan John F.0001601485-21-000058
SEC(opens sec.gov)
Aug 194
Neylan John F.0001601485-21-000052
SEC(opens sec.gov)
Jul 224
Neylan John F.0001601485-21-000038
SEC(opens sec.gov)
Jun 214
Neylan John F.0001601485-21-000029
SEC(opens sec.gov)
May 194
Neylan John F.0001601485-21-000025
SEC(opens sec.gov)
Apr 204
Neylan John F.0001601485-21-000013
SEC(opens sec.gov)
Mar 194
Neylan John F.0001567619-21-006685
SEC(opens sec.gov)
Feb 84
Neylan John F.0001567619-21-002413
SEC(opens sec.gov)
Dec 134
Neylan John F.0000899243-18-030881
SEC(opens sec.gov)
Nov 164
Neylan John F.0001114220-18-000110
SEC(opens sec.gov)
Oct 304
Neylan John F.0001114220-18-000100
SEC(opens sec.gov)
Aug 164
Neylan John F.0001114220-18-000093
SEC(opens sec.gov)
Jul 314
Neylan John F.0001114220-18-000086
SEC(opens sec.gov)
May 164
Neylan John F.0001114220-18-000055
SEC(opens sec.gov)

Companies

Address

C/O KERYX BIOPHARMACEUTICALS, INC. 750 LEXINGTON AVENUE

NEW YORK, NY, 10022